BioLineRx - 53 Year Dividend History | BLRX
Historical dividend payout and yield for BioLineRx (BLRX) since 1971. The current TTM dividend payout for BioLineRx (BLRX) as of November 20, 2024 is $0.00. The current dividend yield for BioLineRx as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.043B |
$0.005B |
|
Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company's portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
